Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.

We offer a fast, reliable platform for ordering Tempus tests, accessing patient insights, and utilizing our AI-driven technologies seamlessly. The first generative AI-enabled clinical assistant that provides …

For clinicians associated with advanced research initiatives, Tempus provides next-generation genomic profiling, biological organoid modeling, image/pattern AI recognition, and a range of clinical trial and …

We’re looking for people who can change the world. Who question the status quo and don’t shy away from tough problems. For the builders who are never done building and the learners who are never …

Tempus Unlimited exists to provide a continuum of community based services that support the efforts of children and adults with disabilities to live as independently as possible in the least restrictive …

Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. The company went public on the …

TEMPUS® is a technology company that has built the world's largest library of clinical and molecular data and an operating system to make that information accessible and useful for patients, physicians …

In order to access your patient portal, look for an email from Tempus with instructions to create your password and access your patient portal. Monitor your PGx order status, and receive updates to …

5 days ago · Tempus AI is rated a strong buy for risk-tolerant investors, leveraging its vast proprietary healthcare data to drive precision medicine via AI and ML. Learn more on TEM stock here.

Aug 11, 2025 · As the industry pivots toward data-driven solutions to address rising costs and complex patient needs, Tempus emerges as a leader, particularly in oncology, by leveraging cutting-edge …